Trial intelligence / Profile preview

Leptin in the Maintenance of Reduced Body Weight

NCT01155180Phase 2Completed

Sponsor
Beth Israel Deaconess Medical Center
Start
Jul 2008
Primary completion
Dec 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of metreleptin in obesity, sponsored by Beth Israel Deaconess Medical Center. Started Jul 2008; status: completed.

02

Drugs

metreleptin
03

Conditions

obesity

Beyond the preview

Go deeper on NCT01155180.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01155180.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call